Nuveen’s ClearPoint Neuro CLPT Stock Holding History

Nuveen’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$569K	Buy	62,502 +483	+0.8%	+$6.1K	﹤0.01%	2788
2025 Q4	$848K	Hold	62,019	–	–	﹤0.01%	2688
2025 Q3	$1.35M	Hold	62,019	–	–	﹤0.01%	2476
2025 Q2	$741K	Buy	+62,019	New	+$780K	﹤0.01%	2736
2024 Q2	–	Sell	-33,564	Closed	-$228K	–	3349
2024 Q1	$228K	Buy	33,564 +1,769	+6%	+$12.4K	﹤0.01%	3158
2023 Q4	$216K	Hold	31,795	–	–	﹤0.01%	3206
2023 Q3	$159K	Hold	31,795	–	–	﹤0.01%	3075
2023 Q2	$230K	Buy	+31,795	New	+$270K	﹤0.01%	3061
2022 Q2	–	Sell	-44,545	Closed	-$416K	–	3284
2022 Q1	$416K	Hold	44,545	–	–	﹤0.01%	3066
2021 Q4	$480K	Hold	44,545	–	–	﹤0.01%	3081
2021 Q3	$874K	Hold	44,545	–	–	﹤0.01%	3034
2021 Q2	$850K	Buy	+44,545	New	+$861K	﹤0.01%	3063

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Nuveen's CLPT Position: Q1 2026 in Review

Nuveen increased its ClearPoint Neuro (CLPT) stake by 0.78% in Q1 2026, buying an estimated $6.1K and bringing the position to 62,502 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Nuveen first reported a position in CLPT in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.35M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Nuveen held 62,502 shares of ClearPoint Neuro worth $569K as of Q1 2026.
Nuveen bought 483 ClearPoint Neuro shares in Q1 2026, an estimated $6.1K.
ClearPoint Neuro made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2788 holding.
Nuveen first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 12 quarters since.
Nuveen's ClearPoint Neuro position peaked at $1.35M in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.